Company Overview
CDC works 24/7 keeping America safe from health, safety and security threats, both foreign and domestic. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights it and supports communities and citizens to prevent it. CDC is the nation’s health protection agency - saving lives, protecting people from health threats, and saving money through prevention.

CDC's Office of Technology and Innovation (OTI) within the Office of Science:
• Fosters, and develops innovative science, technologies, processes, and policies that support CDC’s ability to protect and promote the health of Americans and people around the world,
• Provides leadership, coordination, and support for technology transfer and innovation in CDC science,
• Supports scientific outreach, training, and collaboration in research and development (R&D) activities that advance CDC’s mission and engage other agencies, global partners, academia, innovators, and consumers.

There are several functional areas of OTI:
• The Technology Transfer Office (TTO) supports and facilitates technology development and transfer activities. For CDC, technology transfer is the process by which the agency’s scientific knowledge and inventions developed under federal R&D funding are transferred to other organization(s) for further development and public health benefit. TTO staff work closely with partners such as the National Institutes of Health (NIH), CDC investigators, and outside collaborators to facilitate commercialization efforts for advancing public health. CDC has several kinds of technologies available for licensing and/or collaboration. Patented technologies (for commercialization) can include: vaccine candidates, diagnostics (bacterial, viral, parasital, and fungal) and test kit components such as reagents, early therapeutics, devices/software, and occupational safety and health inventions. Non-patented technologies can include: biological materials and research tools such as isolates, cell lines, hybridomas, etc. See “available CDC Technologies” at

• The Innovation Lab (I-Lab) promotes and facilitates solutions and innovative approaches to advance public health across the agency. Key I-Lab programs and activities include CDC’s Small Business Innovation Research (SBIR) program, CDC’s Innovation Fund (iFund), Ideation Catalyst (iCatalyst) training, citizen science, challenges, contests, and more. The I-Lab supports innovation and entrepreneurship among staff and works to cultivate creativity within the CDC community.